
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (8) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (9) Apply Biologicals filter
- Blood and blood components (4) Apply Blood and blood components filter
- Complementary medicines (22) Apply Complementary medicines filter
- Cosmetics (2) Apply Cosmetics filter
- Disinfectants/Sterilants (4) Apply Disinfectants/Sterilants filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (23) Apply Labelling/Packaging filter
- Legislation (20) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (11) Apply Manufacturing filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medical devices/IVDs (48) Apply Medical devices/IVDs filter
- Medicinal cannabis (1) Apply Medicinal cannabis filter
- Medicines (1) Apply Medicines filter
- OTC medicines (31) Apply OTC medicines filter
- Prescription medicines (25) Apply Prescription medicines filter
- Safety of medicines & medical devices (2) Apply Safety of medicines & medical devices filter
- Scheduling (37) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (6) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (6) Apply Therapeutic goods regulation filter
Proposed amendments to the Poisons Standard - Joint ACCS/ACMS meeting, July 2017
Closed on 7 July 2017
Revision of TGO 75 Standard for haematopoietic progenitor cells derived from cord blood
Closed on 7 July 2017
Comparable overseas regulators - medical devices
Closed on 30 June 2017
Proposed Amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS/ACMS meetings, July 2017
Closed on 15 June 2017
TGA - enhancing sanctions and penalties in the Therapeutic Goods Act 1989
Closed on 31 May 2017
Options for the future regulation of 'low risk' products
Closed on 12 May 2017
Strengthening monitoring of medicines in Australia
Closed on 1 May 2017
Provisional Approval pathway for prescription medicines
Closed on 1 May 2017